What does evidence tier mean in peptide research?

Evidence tiers classify peptides by the strength and quality of clinical research supporting their use. A higher tier means stronger evidence, such as large randomized controlled trials and FDA approval, while lower tiers indicate the evidence is limited to animal studies or early-phase human trials. Understanding the evidence tier helps patients and providers make informed decisions about which peptides have the most robust safety and efficacy data.